Benzinga | Aug 19, 2021 09:56AM EDT

Morgan Stanley Maintains Overweight on Vistra, Lowers Price Target to $25

Morgan Stanley analyst Stephen Byrd maintains Vistra (NYSE:VST) with a Overweight and lowers the price target from $27 to $25.